These are self-pay prices and do not take into account any discounts or prescription insurance coverage that you may have. Actual prices are calculated at the time your prescription is processed by the pharmacy.
A Titrate‐to‐Goal Study of Switching Patients Uncontrolled on Antihypertensive Monotherapy to Fixed‐Dose Combinations of Amlodipine and Olmesartan Medoxomil ± Hydrochlorothiazide J Clin Hypertens (Greenwich).In the prospective, open‐label, titrate‐to‐goal Blood Pressure Control in All Subgroups With Hypertension (BP‐CRUSH) study, 999 patients with hypertension uncontrolled on monotherapy (mean age, 55.6±11.4 years; baseline blood pressure [BP], 153.7±9.2/91.9±8.6 mm Hg) were switched to fixed‐dose amlodipine/olmesartan medoxomil (AML/OM) 5/20 mg. Patients were uptitrated every 4 weeks to AML/OM 5/40 mg and 10/40 mg to achieve BP lt;120/70 mm Hg. Patients were subsequently uptitrated every 4 weeks to AML/OM+hydrochlorothiazide (HCTZ) 10/40+12.5 mg and 10/40+25 mg to achieve BP lt;125/75 mm Hg. The primary end point, the cumulative percentage of patients achieving seated systolic BP lt;140 mm Hg (lt;130 mm Hg for patients with d...